Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05321> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05321 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05321 label "PEG-uricase [drugbank:DB05321]" assertion.
- drugbank:DB05321 seeAlso DB05321 assertion.
- drugbank:DB05321 description "PEG-uricase, a polyethylene glycol ("PEG") conjugate of recombinant porcine uricase (urate oxidase), which breaks down the uric acid deposits is being studied in Phase III clinical trials for the treatment of severe, treatment-refractory gout in the United States in 2006." assertion.
- drugbank:DB05321 identifier "drugbank:DB05321" assertion.
- drugbank:DB05321 title "PEG-uricase" assertion.
- drugbank:DB05321 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05321 drugbank_vocabulary:drugbank-id "DB05321" assertion.
- drugbank:DB05321 bio2rdf_vocabulary:x-identifiers.org DB05321 assertion.
- drugbank:DB05321 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05321" assertion.
- drugbank:DB05321 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05321 bio2rdf_vocabulary:identifier "DB05321" assertion.